Related Experiment Video
Updated: Aug 6, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Impact of changes in sarcopenia status on incident cardiovascular disease and mortality in older adults
Na-Noom Jeong1, Hyun Joung Lim1, Chang Oh Kim2
1Division of Cardiovascular Disease Research, Department of Chronic Disease Convergence Research, National Institute of Health, 187, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju, 28159, Republic of Korea.
Abstract:
Sarcopenia is an independent risk factor for cardiovascular disease (CVD) and mortality. However, the impact of longitudinal changes in sarcopenia remains unclear. We investigated the relationship between changes in sarcopenia status and the risk of CVD and mortality in older Korean adults. This study included 2,997 older adults aged ≥ 65 years from the Korea Urban and Rural Elderly Study. Sarcopenia status was classified as non-sarcopenia, possible sarcopenia, or functional sarcopenia. Changes in sarcopenia status were assessed at baseline and during a follow-up visit 4 years later. Incident CVD was defined as hospitalization for ischemic heart disease or cerebrovascular disease. All-cause mortality was determined using death records provided by Statistics Korea. Associations were evaluated using Cox proportional hazards regression models. During the follow-up, a total of 423 incident CVD cases and 438 deaths were identified. At baseline, individuals with functional sarcopenia had a higher risk of incident CVD and mortality than those without, after adjusting for all covariates. Similarly, participants who progressed from non-sarcopenia to sarcopenia or had stable sarcopenia showed increased CVD and mortality risk. Sarcopenia was associated with elevated risks of CVD and mortality. Early identification and management of sarcopenia may help reduce adverse outcomes in older adults.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pharmacodynamics in Geriatric Patients: Effects of Age
The Effect of Aging on Tissues
Coronary Artery Disease I: Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution